Tag Archives: myl

Teva Bids $40 Billion For Mylan, But May Need More

Israeli drug giant Teva Pharmaceutical Industries (TEVA) made its long-awaited bid for competitor Mylan on Tuesday, offering $82 a share, or $40.1 billion. Both stocks rose on the news. Teva’s proposal, half cash and half stock, was unsolicited by Mylan (MYL), which adopted a poison-pill provision this month after initial reports of Teva’s interest emerged. On April 8, Mylan made its own unsolicited bid for fellow generic-drug maker Perrigo (PRGO)

Teva Offers $82 A Share For Mylan; Stocks Rise

Teva Pharmaceutical Industries (TEVA) made a long-rumored bid for smaller generics rival Mylan (MYL) on Tuesday — 82 a share. Both stocks rose in pre-market trading. But over-the-counter products maker Perrigo (PRGO), which has an offer from Mylan, fell in early trading. Israeli-based Teva offered to buy Mylan for $40.1 billion, or 82 a share, in equal parts cash and stock. “The proposed combination of Teva and Mylan would create a leading company

Teva Getting Serious About Mylan Bid, Says Report

Shares of Teva Pharmaceutical Industries (TEVA) abruptly rebounded Friday afternoon on reports that the drugmaker is thinking seriously about bidding for Mylan. Anonymous sources said Teva may or may not make an offer but is evaluating the idea and has approached advisers on the subject, Bloomberg reported. Most of Wall Street has been assuming that Teva was thinking about this at least since March 11, when rumors first emerged that Mylan (MYL)